Alaunos Therapeutics Inc (TCRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 38,932 | 55,655 | 73,306 | 95,333 | 110,391 |
| Receivables | 31 | 72 | 58 | 13 | N/A |
| TOTAL | $43,030 | $60,561 | $80,276 | $102,581 | $119,442 |
| Non-Current Assets | |||||
| PPE Net | 1,713 | 1,909 | 1,994 | 2,108 | 1,982 |
| Other Non-Current Assets | 860 | 876 | 1,134 | 951 | 956 |
| TOTAL | $2,573 | $2,785 | $3,128 | $3,059 | $2,938 |
| Total Assets | $45,603 | $63,346 | $83,404 | $105,640 | $122,380 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,165 | 983 | 1,509 | 4,248 | 1,470 |
| Accrued Expenses | 18,969 | 18,521 | 16,516 | 16,682 | 15,502 |
| TOTAL | $20,997 | $20,362 | $18,864 | $21,736 | $17,776 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 863 | 858 | 839 | 806 | 804 |
| Other Non-Current Liabilities | 2,576 | 2,174 | 12,962 | 21,528 | 25,472 |
| TOTAL | $5,274 | $5,091 | $16,095 | $24,876 | $28,968 |
| Total Liabilities | $26,271 | $25,453 | $34,959 | $46,612 | $46,744 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 557 | 557 | 558 | 531 | 531 |
| Common Shares | 84 | 84 | 83 | 80 | 80 |
| Retained earnings | -315,215 | -296,523 | -283,724 | -253,499 | -235,675 |
| TOTAL | $19,332 | $37,893 | $48,445 | $59,028 | $75,636 |
| Total Liabilities And Equity | $45,603 | $63,346 | $83,404 | $105,640 | $122,380 |